 Matthew Stone
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 10 | 2022 | 499 | 3.300 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2022 | 40 | 1.960 |
Why?
| | Ventricular Outflow Obstruction | 2 | 2022 | 40 | 1.550 |
Why?
| | Computed Tomography Angiography | 2 | 2023 | 114 | 1.540 |
Why?
| | Aortic Diseases | 3 | 2022 | 113 | 1.480 |
Why?
| | Double Outlet Right Ventricle | 2 | 2022 | 8 | 1.430 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2022 | 385 | 1.390 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 218 | 1.300 |
Why?
| | Heart Transplantation | 4 | 2023 | 721 | 1.110 |
Why?
| | Fontan Procedure | 4 | 2023 | 173 | 1.100 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2021 | 117 | 1.000 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 527 | 0.930 |
Why?
| | Postoperative Complications | 7 | 2020 | 2473 | 0.900 |
Why?
| | Heart Defects, Congenital | 4 | 2023 | 757 | 0.860 |
Why?
| | Central Venous Catheters | 2 | 2022 | 48 | 0.840 |
Why?
| | Coronary Circulation | 2 | 2022 | 138 | 0.810 |
Why?
| | Aortic Coarctation | 1 | 2023 | 82 | 0.810 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 20 | 0.790 |
Why?
| | Atrioventricular Block | 1 | 2022 | 35 | 0.780 |
Why?
| | Fibroma | 1 | 2022 | 22 | 0.780 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 103 | 0.780 |
Why?
| | Heart Neoplasms | 1 | 2022 | 49 | 0.770 |
Why?
| | Aorta, Thoracic | 2 | 2023 | 262 | 0.760 |
Why?
| | Hemodynamics | 3 | 2021 | 1090 | 0.750 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.710 |
Why?
| | Coronary Vessels | 1 | 2022 | 239 | 0.700 |
Why?
| | Echocardiography | 1 | 2023 | 629 | 0.700 |
Why?
| | Coronary Angiography | 1 | 2022 | 305 | 0.690 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 283 | 0.650 |
Why?
| | Child | 19 | 2023 | 20773 | 0.640 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 29 | 0.610 |
Why?
| | Tissue and Organ Procurement | 1 | 2022 | 288 | 0.610 |
Why?
| | Vascular Stiffness | 2 | 2020 | 467 | 0.610 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2018 | 5 | 0.610 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 68 | 0.590 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 1946 | 0.590 |
Why?
| | Septal Occluder Device | 1 | 2018 | 30 | 0.580 |
Why?
| | Nicardipine | 1 | 2017 | 6 | 0.570 |
Why?
| | Infant | 9 | 2023 | 8975 | 0.570 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 178 | 0.570 |
Why?
| | Laparoscopy | 2 | 2012 | 449 | 0.550 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 518 | 0.540 |
Why?
| | Heart Ventricles | 5 | 2023 | 781 | 0.530 |
Why?
| | Calcium Channel Blockers | 1 | 2017 | 161 | 0.530 |
Why?
| | Respiration, Artificial | 1 | 2019 | 613 | 0.480 |
Why?
| | Aortic Valve | 3 | 2023 | 347 | 0.470 |
Why?
| | Humans | 43 | 2023 | 129248 | 0.450 |
Why?
| | Surgical Procedures, Operative | 2 | 2013 | 244 | 0.420 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 80 | 0.410 |
Why?
| | Retrospective Studies | 11 | 2023 | 14455 | 0.410 |
Why?
| | Ethics, Medical | 1 | 2012 | 78 | 0.390 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2012 | 4 | 0.390 |
Why?
| | Coronary Sinus | 1 | 2012 | 7 | 0.380 |
Why?
| | Peritoneal Dialysis | 1 | 2013 | 95 | 0.380 |
Why?
| | Health Resources | 1 | 2013 | 113 | 0.380 |
Why?
| | Pericardium | 1 | 2012 | 54 | 0.370 |
Why?
| | Infant, Newborn | 6 | 2023 | 5736 | 0.370 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 28 | 0.370 |
Why?
| | Treatment Outcome | 11 | 2022 | 10199 | 0.370 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 69 | 0.360 |
Why?
| | Renal Insufficiency | 1 | 2013 | 149 | 0.360 |
Why?
| | Suture Techniques | 1 | 2011 | 118 | 0.350 |
Why?
| | Diagnostic Errors | 1 | 2012 | 162 | 0.350 |
Why?
| | Tobacco Products | 2 | 2022 | 110 | 0.350 |
Why?
| | Insurance, Health | 1 | 2013 | 265 | 0.340 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2012 | 177 | 0.340 |
Why?
| | Child, Preschool | 8 | 2022 | 10456 | 0.330 |
Why?
| | Male | 24 | 2023 | 63501 | 0.330 |
Why?
| | Tetralogy of Fallot | 2 | 2020 | 78 | 0.310 |
Why?
| | Hospital Mortality | 2 | 2013 | 846 | 0.310 |
Why?
| | Hypertension | 1 | 2017 | 1242 | 0.300 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 295 | 0.290 |
Why?
| | Incidence | 5 | 2022 | 2636 | 0.290 |
Why?
| | Smoking Cessation | 2 | 2022 | 405 | 0.290 |
Why?
| | Aorta | 4 | 2020 | 408 | 0.280 |
Why?
| | Female | 23 | 2023 | 68543 | 0.280 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 185 | 0.260 |
Why?
| | Heart | 2 | 2020 | 637 | 0.240 |
Why?
| | Product Labeling | 2 | 2022 | 6 | 0.240 |
Why?
| | Adenocarcinoma | 1 | 2012 | 898 | 0.230 |
Why?
| | Pulmonary Artery | 3 | 2020 | 1095 | 0.230 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 39 | 0.230 |
Why?
| | Time Factors | 6 | 2022 | 6543 | 0.230 |
Why?
| | Jugular Veins | 2 | 2022 | 40 | 0.210 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 36 | 0.210 |
Why?
| | Sternotomy | 1 | 2022 | 25 | 0.200 |
Why?
| | Fetal Diseases | 1 | 2023 | 158 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 110 | 0.190 |
Why?
| | Risk Factors | 6 | 2022 | 9745 | 0.180 |
Why?
| | Trachea | 2 | 2021 | 220 | 0.180 |
Why?
| | Norwood Procedures | 1 | 2021 | 29 | 0.170 |
Why?
| | Waiting Lists | 1 | 2022 | 237 | 0.170 |
Why?
| | Adolescent | 6 | 2021 | 20303 | 0.170 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 202 | 0.170 |
Why?
| | Cigarette Smoking | 1 | 2021 | 91 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 427 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 89 | 0.160 |
Why?
| | Calcinosis | 1 | 2021 | 231 | 0.150 |
Why?
| | Cannula | 1 | 2018 | 20 | 0.150 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 191 | 0.150 |
Why?
| | Young Adult | 4 | 2020 | 12388 | 0.150 |
Why?
| | Recurrence | 1 | 2021 | 1005 | 0.150 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 757 | 0.140 |
Why?
| | Smoking | 2 | 2022 | 1499 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 857 | 0.140 |
Why?
| | Heart-Assist Devices | 2 | 2012 | 539 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2021 | 3377 | 0.120 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3079 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1482 | 0.110 |
Why?
| | Research Design | 1 | 2020 | 1043 | 0.110 |
Why?
| | Double-Blind Method | 1 | 2018 | 1875 | 0.110 |
Why?
| | Risk Assessment | 3 | 2019 | 3233 | 0.110 |
Why?
| | Rural Health | 1 | 2013 | 70 | 0.100 |
Why?
| | Hospital Charges | 1 | 2013 | 41 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 68 | 0.100 |
Why?
| | Catheterization | 1 | 2013 | 174 | 0.100 |
Why?
| | Risk Adjustment | 1 | 2013 | 79 | 0.100 |
Why?
| | Tricuspid Valve | 1 | 2012 | 27 | 0.100 |
Why?
| | Medically Uninsured | 1 | 2013 | 126 | 0.100 |
Why?
| | Anxiety | 1 | 2019 | 962 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 57 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 85 | 0.090 |
Why?
| | Perfusion | 1 | 2012 | 197 | 0.090 |
Why?
| | Cryosurgery | 1 | 2012 | 57 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2537 | 0.090 |
Why?
| | Sirolimus | 1 | 2013 | 266 | 0.090 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2012 | 208 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 299 | 0.090 |
Why?
| | Medicare | 2 | 2013 | 706 | 0.090 |
Why?
| | Esophagectomy | 1 | 2012 | 125 | 0.090 |
Why?
| | Logistic Models | 2 | 2013 | 1984 | 0.090 |
Why?
| | Linear Models | 1 | 2013 | 819 | 0.080 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 286 | 0.080 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 167 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2013 | 396 | 0.080 |
Why?
| | Age Factors | 1 | 2017 | 3140 | 0.080 |
Why?
| | Lung Transplantation | 1 | 2012 | 289 | 0.080 |
Why?
| | Health Care Costs | 1 | 2012 | 367 | 0.080 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 219 | 0.080 |
Why?
| | Systole | 2 | 2020 | 191 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 794 | 0.080 |
Why?
| | Intensive Care Units | 1 | 2014 | 736 | 0.080 |
Why?
| | Prospective Studies | 2 | 2018 | 7121 | 0.080 |
Why?
| | Cattle | 1 | 2012 | 977 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1497 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2010 | 152 | 0.080 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2011 | 203 | 0.080 |
Why?
| | Medicaid | 1 | 2013 | 431 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1430 | 0.070 |
Why?
| | Cohort Studies | 3 | 2023 | 5408 | 0.070 |
Why?
| | Length of Stay | 1 | 2013 | 1120 | 0.070 |
Why?
| | Databases, Factual | 1 | 2013 | 1266 | 0.070 |
Why?
| | Stroke Volume | 2 | 2020 | 592 | 0.070 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 514 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2014 | 4886 | 0.060 |
Why?
| | Prognosis | 1 | 2012 | 3772 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2023 | 4076 | 0.060 |
Why?
| | United States | 3 | 2021 | 13828 | 0.050 |
Why?
| | Virginia | 2 | 2014 | 60 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 160 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 96 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2010 | 790 | 0.050 |
Why?
| | Aged | 6 | 2021 | 22032 | 0.050 |
Why?
| | Middle Aged | 7 | 2021 | 31087 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 308 | 0.050 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 161 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2515 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 336 | 0.050 |
Why?
| | Smokers | 1 | 2022 | 138 | 0.050 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 8 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 621 | 0.050 |
Why?
| | Tobacco Use | 1 | 2021 | 61 | 0.040 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 37 | 0.040 |
Why?
| | Adult | 5 | 2021 | 35495 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 39 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3386 | 0.040 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2020 | 36 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2135 | 0.040 |
Why?
| | Lung | 1 | 2012 | 3926 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 181 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 190 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 145 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2021 | 463 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2020 | 335 | 0.040 |
Why?
| | Signal Transduction | 2 | 2023 | 4926 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1584 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 406 | 0.040 |
Why?
| | Blotting, Western | 1 | 2021 | 1204 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 978 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 255 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2020 | 276 | 0.030 |
Why?
| | Animals | 3 | 2013 | 35307 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 873 | 0.030 |
Why?
| | RNA | 1 | 2021 | 880 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2716 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 79 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 83 | 0.030 |
Why?
| | Warm Ischemia | 1 | 2012 | 12 | 0.030 |
Why?
| | Citrates | 1 | 2012 | 42 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 46 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4057 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 78 | 0.020 |
Why?
| | Organ Preservation Solutions | 1 | 2012 | 45 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 120 | 0.020 |
Why?
| | Cold Ischemia | 1 | 2012 | 30 | 0.020 |
Why?
| | Reoperation | 1 | 2014 | 541 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 3966 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 400 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 118 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 262 | 0.020 |
Why?
| | Cold Temperature | 1 | 2012 | 154 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 218 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2012 | 580 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 372 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2012 | 306 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1247 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 569 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 1869 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 127 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 2012 | 272 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6391 | 0.020 |
Why?
| | Tissue Donors | 1 | 2012 | 391 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1269 | 0.020 |
Why?
| | Risk | 1 | 2012 | 854 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 505 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 164 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1288 | 0.020 |
Why?
| | Heart Arrest | 1 | 2012 | 320 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 944 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2012 | 867 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 339 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5382 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1018 | 0.020 |
Why?
| | Contrast Media | 1 | 2010 | 393 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1202 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1197 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5439 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7055 | 0.010 |
Why?
| | Mice | 1 | 2013 | 16915 | 0.010 |
Why?
|
|
Stone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|